CRP and fibrosis: To identify risk factors potentially influencing MASLD development among patients diagnosed with IBD, statistical associations between IBD type, HBI, Mayo Score, CRP levels, fecal calprotectin, and the presence of hepatic steatosis/fibrosis were examined.